Fundraising Fox

Craig Asher

Investor

Managing Director at OMX Ventures Β· Board director at Glyphic Biotechnologies Β· Founder at Matterworks

Washington, District of Columbia

Writes $500K – $15M checks Β· typically $7.8M

About

Craig Asher is a co-founder and managing partner of OMX Ventures, which he helped form in 2020. He previously worked as an early-stage biotech investor from 2009 to 2020, backing companies including QuantaLife, 10X Genomics, Twist Bioscience, Ginkgo Bioworks, and CD Diagnostics. Earlier in his career he worked as a manufacturing engineer and held roles at Trigo Technologies (later IBM), and he holds a degree from Stanford University plus an MBA and MS in Industrial Engineering from Northwestern University.

ContactΒ· self-published, not guessed

Invests in

Biotech

Board director at Glyphic Biotechnologies

Intro paths

β†’

In turn, Craig can intro founders to Glyphic Biotechnologies's investors below.

Glyphic Biotechnologies's investors Β· 11

Artis VenturesSan Francisco Β· $50K – $25M checks Β· since 2024Axial VCSan Francisco Β· $100K – $5M checks Β· since 2024Black FlagSan Diego Β· $100K – $1M checks Β· since 2024Cantos VenturesSan Francisco Β· $400K – $1.5M checks Β· since 2024Civilization Ventures Management, LlcTiburon Β· $1M – $10M checks Β· since 2024FoundersX VenturesSilicon Valley Β· since 2024LongeVCWashington D.C. Β· since 2024Modi VenturesHouston Β· since 2024National Institutes of Health (NIH)since 2022OMX VenturesLincolnshire Β· since 2024WingPalo Alto Β· $200K – $20M checks Β· since 2024

Co-founders at Glyphic Biotechnologies

DE
Daniel EstandianFounder
EB
Ed BoydenFounder
JY
Josh YangFounder

Founder at Matterworks

Intro paths

β†’

In turn, Craig can intro founders to Matterworks's investors below.

Matterworks's investors Β· 5

Germin8 VenturesChicagoiGlobe PartnersSingapore Β· $600K – $6M checksPillar VCBoston Β· $50K – $4M checksWavemaker Three-Sixty HealthLos Angeles Β· $500K – $2M checksWingPalo Alto Β· $200K – $20M checks

Co-founders at Matterworks

J(
Jack (J.M.) Geremia
J(
Jack (J.M.) Geremia, PhD
EC
Eric Carlson, PhD

Experience

  1. OMX VenturesManaging Directorcurrent2020 β€” presentWashington, District of Columbia, United States
  2. Syndex BioBoard Observercurrent2025 β€” presentCambridgeshire, England, United Kingdom
  3. Constructive BioBoard Observercurrent2022 β€” presentCambridgeshire, England, United Kingdom
  4. Glyphic BiotechnologiesBoard Membercurrent2021 β€” presentSan Francisco Bay Area
  5. VedaBioBoard Membercurrent2021 β€” presentSan Diego, California, United States
  6. MatterworksBoard Membercurrent2020 β€” presentBoston, Massachusetts, United States
  7. Lightcast DiscoveryBoard Observercurrent2021 β€” presentCambridge, England, United Kingdom
  8. Merieux Equity PartnersStrategic Advisorcurrent2020 β€” present
  9. Aperiam BioBoard Observercurrent2022 β€” presentAustin, Texas, United States
  10. Menlo MicroBoard Observercurrent2016 β€” presentOrange County, California, United States
  11. Tessera TherapeuticsInvestorcurrent2020 β€” presentBoston, Massachusetts, United States
  12. Trancos VenturesManaging Partnercurrent2016 β€” presentWashington DC-Baltimore Area
  13. CircadenceBoard Membercurrent2012 β€” presentBoulder, CO
  14. Hexagon BioInvestorcurrent2017 β€” presentSan Francisco Bay Area
  15. Delix TherapeuticsInvestorcurrent2019 β€” presentBoston, Massachusetts, United States
  16. ManusInvestorcurrent2017 β€” presentPleasanton, California, United States
  17. 10x GenomicsInvestorcurrent2012 β€” presentPleasanton, California, United States
  18. SyntheX, Inc.Investorcurrent2017 β€” presentSan Francisco, CA
  19. Vital Venture Capital LLCPrincipalcurrent2008 β€” presentWashington DC-Baltimore Area
  20. ReplayInvestor2022 β€” 2026San Diego, California, United States
  21. Mythic Therapeutics, Inc.Investor2020 β€” 2025Waltham, Massachusetts, United States
  22. Sestina Bio, LLC.Investor2020 β€” 2022Pleasanton, California, United States
  23. TARA Biosystems, Inc.Board Member2017 β€” 2022New York City Metropolitan Area
  24. Halfpenny TechnologiesBoard Observer2012 β€” 2019Greater Philadelphia
  25. Verodin Inc.Board Observer2015 β€” 2019Reston, VA
  26. Twist BioscienceBoard Observer2013 β€” 2018San Francisco Bay Area
  27. Booker SoftwareInvestor2011 β€” 2018New York City Metropolitan Area
  28. CD DiagnosticsInvestor2012 β€” 2016Wilmington, DE
  29. AxioMx IncBoard Observer2013 β€” 2015New York City Metropolitan Area
  30. Shoefitr Inc.Board Member2011 β€” 2015Greater Pittsburgh Region
  31. QuantaLife, Inc.Board Observer2011Pleasanton, CA
  32. CardioReadyActing CTO2008 β€” 2010
  33. IBMMgr, Product Mgmt for RFID Information Center2004 β€” 2008
  34. Trigo TechnologiesDirector of Product Management2001 β€” 2004Burlingame, CA
  35. Commerce OneDirector Product Management1999 β€” 2001
  36. AccentureSenior Consultant1995 β€” 1998

Skills & more

Management19Leadership4Strategy27Negotiation1Strategic Planning5Product Management69Venture Capital56Product Development12Marketing6Quality Assurance2Start-ups93Product Marketing22
+12 moreStrategic PartnershipsEntrepreneurshipGo-to-market StrategyExecutive ManagementCloud ComputingCompetitive AnalysisMobile DevicesTelecommunicationsE-commerceAnalyticsDue DiligenceMergers & Acquisitions

Languages English Β· French Β· German Β· Italian Β· Spanish

From Craig's professional profile.

Investments

Investor

10X GenomicsCD DiagnosticsGinkgo BioworksQuantaLifeTwist Bioscience

Per the firm's website.

Colleagues at OMX Ventures

Daniel Fero
Managing Director at OMX Ventures
Fred Sweeney
Venture Partner at OMX Ventures
John Nawrocki
Chief Financial Officer at OMX Ventures
Natasha Azar
Vice President Investor Relations at OMX Ventures
Nicholas Haft
Managing Director at OMX Ventures
Paul Conley
Chairman & CEO at GENERAL INCEPTION
Swetha Murali
Vice President at OMX Ventures
Tim Richardson
Strategic Advisor at GENERAL INCEPTION

Network1

Daniel Fero
Managing Director at OMX Ventures

Investors connected to Craig in public investor directories β€” a warm-intro map.

Frequently asked questions

Who is Craig Asher?
Craig Asher is a co-founder and managing partner of OMX Ventures, which he helped form in 2020. He previously worked as an early-stage biotech investor from 2009 to 2020, backing companies including QuantaLife, 10X Genomics, Twist Bioscience, Ginkgo Bioworks, and CD Diagnostics. Earlier in his career he worked as a manufacturing engineer and held roles at Trigo Technologies (later IBM), and he holds a degree from Stanford University plus an MBA and MS in Industrial Engineering from Northwestern University.
Where does Craig Asher work?
Craig Asher is Managing Director at OMX Ventures and Board director at Glyphic Biotechnologies.
What does Craig Asher invest in?
Craig Asher invests in Biotech.
What check size does Craig Asher write?
Craig Asher typically writes checks of $500K – $15M.
What companies has Craig Asher invested in?
Investments tracked here include 10X Genomics, CD Diagnostics, Ginkgo Bioworks, QuantaLife, Twist Bioscience.
Where did Craig Asher go to school?
Craig Asher studied at Northwestern University (MS, Industrial Engineering); Northwestern University - Kellogg School of Management (Master of Business Administration - MBA, Marketing); Stanford University (AB, Political Science).

Same school

Also attended Northwestern University486

Mikowai AshwillInvestor at Spark CapitalNaomi Pilosof IonitaBoard Partner at Menlo VenturesEric OngInvestor at LightbankBill PescatelloInvestor at LightbankScott JacobsonManaging Director at Madrona Venture GroupAnna WangAssociate at March Capital Partners

+ 480 more

Also attended Northwestern University - Kellogg School of Management753

Jenny LeeSenior Managing Partner at Granite AsiaKunal BahlCo-founder of Snapdeal; co-founder of Titan CapitalCristina JunqueiraCo-founder of NubankAndy FligelSenior Managing Director at Intel CapitalDavid Clark GuillermoInvestments at Impact America FundGiuseppe DonvitoPartner at P101 Ventures

+ 747 more

Also attended Stanford University2,000

Peter ThielCo-founder & Partner at Founders FundReid HoffmanCo-founder of LinkedIn; Partner at GreylockDavid SacksCo-founder & General Partner at Craft Ventures; former White House AI & Crypto CzarKeith RaboisManaging Director at Khosla VenturesGarry TanPresident & CEO of Y CombinatorAlfred LinPartner at Sequoia Capital

+ 1,994 more

Also attended Heidelberg University67

Mojca SkoberneEntrepreneur in Residence at GV (Google Ventures)Keita Yazakiγ‚·γƒ‹γ‚’γƒ»γ‚’γ‚½γ‚·γ‚¨γ‚€γƒˆ (Senior Associate) at CyberAgent CapitalGrace SchattnerChief of Staff at TitletownTechLena ThiedeCo-Founder & General Partner at Planet A VenturesFabian HeilemannFounder & CEO at AENUJan MarchewskiPrincipal at Hitachi Ventures

+ 61 more

Shared employers

Also worked at Lightcast Discovery6

Sean KendallPartner (Europe) at ARCH Venture PartnersBrad CrutchfieldExecutives in Residence at GENERAL INCEPTIONMatthew FrohnManaging Partner and Co-Founder at Longwall Venture Partners LLPWouter MeulemanPartner at Illumina VenturesJonathan NashInvestment Principal at LifeArc VenturesChristian UhrichPrincipal at M Ventures

Also worked at Menlo Micro5

Marianne WuVenture Partner at Congruent VenturesFaie DorinGeneral Counsel & Chief Compliance Officer at Cota CapitalIra EhrenpreisFounder and Managing Partner at DBL PartnersPaul ConleyChairman & CEO at GENERAL INCEPTIONParag JhaveriVenture Partner at VC23 Investors

Also worked at Halfpenny Technologies2

Saul RichterFounder & Managing Partner at Rittenhouse VenturesTodd PietriCo-Founder and Managing Partner at Activate Venture Partners

Also worked at Booker Software2

Scott PettyGP & Senior Advisor at Signal Peak VenturesDon RaineyGeneral Partner at Grotech Ventures